On Target Laboratories Lands $15 Million For Tumor Fluorescing Tech

OnTarget Laboratories says a pair of investors put $15 million into its technology designed to cause tumorous tissue to fluoresce. OnTarget Laboratories said it landed a $15 million investment from a pair of backers for its tumor-lighting technology developed at Purdue University by the founder of Endocyte (NSDQ:ECYT). The OnTarget technology uses small molecules and fluorescent dyes to target and illuminate specific cancerous cells, according to the West Lafayette, Ind.-based company's website.

Help employers find you! Check out all the jobs and post your resume.